Phibro Animal Health Corporation (PAHC) Comparison with companies in other sectors?

Phibro Animal Health Corporation has a share price of 40.53M. You can analyze Phibro Animal Health Corporation (PAHC) competitors across different market sectors through stock heatmaps.

What are PAHC's NET and operating margins?

Phibro Animal Health Corporation (PAHC) operating margin is around 0.08, and net profit margin is approximately 0.03 as of the latest reports.

In what way does PAHC's earnings per share (EPS) trend reflect its financial momentum?

Phibro Animal Health Corporation (PAHC) EPS is 0.78 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Phibro Animal Health Corporation is 37.08, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Phibro Animal Health Corporation?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Phibro Animal Health Corporation like P/E which is 36.80, P/B which is 4.40, and PEG which is 0.57. Compare them with sector averages to evaluate if the stock is priced fairly.

Phibro Animal Health Corporation

PAHC•NASDAQ

Healthcare

Drug Manufacturers - Specialty & Generic

$28.92

$-0.26(-0.89%)

Phibro Animal Health Corporation (PAHC) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.78

P/E Ratio

37.08

ROE

0.12%

Net Margin

0.03%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.17B

Shares OutstandingTotal number of shares issued

$40.53M

Book Value/ShareNet worth per share

$6.57

Revenue/ShareAnnual revenue per share

$29.40

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.78

Net MarginNet income as percentage of revenue

2.67%

Operating MarginOperating income as percentage of revenue

7.51%

ROEReturn on shareholders' equity

12.37%

ROAReturn on total assets

2.41%

ROCEReturn on capital employed

8.51%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.21

Cash/ShareCash and equivalents per share

$1.74

FCF YieldFree cash flow as percentage of market cap

4.19%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.48

Dividend YieldAnnual dividend as percentage of stock price

1.66%

Financial Ratios Analysis data is not available for PAHCFinancial Ratios Analysis details for PAHC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PAHCSector Benchmarking details for PAHC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Phibro Animal Health Corporation Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Phibro Animal Health Corporation. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Phibro Animal Health Corporation's unique business strengths and challenges.

Key Financial Metrics for Phibro Animal Health Corporation

For Phibro Animal Health Corporation, essential financial indicators include EPS 0.78, PE 37.08, and ROE 0.12. These key ratios reveal insights into Phibro Animal Health Corporation's profitability, valuation, and operational health. Understanding these metrics enables you to compare Phibro Animal Health Corporation with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Phibro Animal Health Corporation

Metrics like Net Margin 2.67% and ROA 2.41% shed light on how well Phibro Animal Health Corporation is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Phibro Animal Health Corporation can sustain its operations and continue growing in the future.

Valuation and Market Position of Phibro Animal Health Corporation

Using ratios such as P/B Ratio 4.40 and PEG Ratio 0.57, investors can assess whether Phibro Animal Health Corporation is appropriately valued based on its financials and growth potential. These figures, combined with Phibro Animal Health Corporation's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Phibro Animal Health Corporation

Financial health indicators, such as Debt/Equity Ratio 2.89 and Cash Flow $1.21, provide a snapshot of Phibro Animal Health Corporation's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Phibro Animal Health Corporation, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Phibro Animal Health Corporation

Investing in Phibro Animal Health Corporation based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Phibro Animal Health Corporation focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;